We are live on ! Find out more
Brian C. Broderick

Brian C. Broderick Portfolio holdings

AUM $660M Turnover 6.12%
1-Year Est. Return 39.39%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+39.39%
3 Year Est. Return
+113.87%
5 Year Est. Return
+133.67%
10 Year Est. Return
+411.02%
AUM
$274M
AUM Growth
-$3.18M
Cap. Flow
-$15.6M
Cap. Flow %
-5.71%
Top 10 Hldgs %
31.18%
Holding
103
New
12
Increased
21
Reduced
50
Closed
13
Avg Time Held
3.1 years
Top 10 Avg Time Held
2.4 years
Top 20 Avg Time Held
3.2 years

Top Buys

Rank Stock Value
1
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$5.34M
2
EOG icon
EOG Resources
EOG
+$1.23M
3
CELG
Celgene
CELG
+$956K
4
FTV icon
Fortive
FTV
+$814K
5
ADI icon
Analog Devices
ADI
+$744K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$1.88M
2
SLB icon
SLB
SLB
+$1.78M
3
NXPI icon
NXP Semiconductors
NXPI
+$1.53M
4
SJM icon
J.M. Smucker
SJM
+$1.37M
5
JNJ icon
Johnson & Johnson
JNJ
+$1.23M

Sector Composition

Rank Sector Weight
1 Healthcare 22.48%
2 Technology 22.04%
3 Industrials 15.43%
4 Miscellaneous 13.25%
5 Consumer Staples 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
JNJ icon
1
Johnson & Johnson
JNJ
$674B
$9.6M 3.52%
68,994
-8,827
-11% -$1.23M
2013 Q2
18 quarters
MA icon
2
Mastercard
MA
$570B
$9.13M 3.33%
60,290
-4,190
-6% -$623K
2013 Q2
18 quarters
MMM icon
3
3M
MMM
$93.9B
$8.93M 3.26%
45,363
-9,775
-18% -$1.88M
2013 Q2
18 quarters
CNI icon
4
Canadian National Railway
CNI
$75.9B
$8.69M 3.17%
105,378
-5,633
-5% -$454K
2013 Q2
18 quarters
PG icon
5
Procter & Gamble
PG
$401B
$8.57M 3.13%
93,274
-11,270
-11% -$1.01M
2013 Q2
18 quarters
AAPL icon
6
Apple
AAPL
$5.16T
$8.55M 3.12%
202,044
-24,584
-11% -$1.03M
2013 Q2
18 quarters
HD icon
7
Home Depot
HD
$343B
$8.13M 2.97%
42,898
+76
+0.2% +$13.1K
2013 Q2
18 quarters
ADP icon
8
Automatic Data Processing
ADP
$123B
$8.01M 2.93%
68,363
-7,537
-10% -$862K
2013 Q2
18 quarters
XOM icon
9
ExxonMobil
XOM
$686B
$7.64M 2.79%
91,295
+2,556
+3% +$211K
2013 Q2
18 quarters
NVS icon
10
Novartis
NVS
$300B
$7.57M 2.76%
100,669
-4,499
-4% -$339K
2013 Q2
18 quarters
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$3.48T
$7.55M 2.76%
143,380
-12,540
-8% -$647K
2015 Q3
9 quarters
IRWD icon
12
Ironwood Pharmaceuticals
IRWD
$801M
$7.3M 2.67%
581,556
+409,052
+237% +$5.34M
2013 Q2
18 quarters
ATR icon
13
AptarGroup
ATR
$9.02B
$7.3M 2.66%
84,575
-10,956
-11% -$955K
2013 Q2
18 quarters
ROK icon
14
Rockwell Automation
ROK
$43B
$6.83M 2.49%
34,810
-4,890
-12% -$932K
2013 Q2
18 quarters
CB icon
15
Chubb
CB
$145B
$6.78M 2.48%
46,403
-348
-0.7% -$52K
2015 Q3
9 quarters
FISV icon
16
Fiserv
FISV
$33.6B
$6.74M 2.46%
102,764
-7,368
-7% -$476K
2013 Q2
18 quarters
ABT icon
17
Abbott
ABT
$186B
$6.64M 2.42%
116,410
-8,860
-7% -$491K
2013 Q2
18 quarters
INTC icon
18
Intel
INTC
$290B
$6.5M 2.37%
140,698
-12,301
-8% -$537K
2013 Q2
18 quarters
RTX icon
19
RTX
RTX
$266B
$6.42M 2.34%
79,947
+6,869
+9% +$522K
2013 Q2
18 quarters
DHR icon
20
Danaher
DHR
$160B
$6.4M 2.34%
77,749
+8,027
+12% +$653K
2016 Q1
7 quarters
ADI icon
21
Analog Devices
ADI
$189B
$6.15M 2.25%
69,108
+8,398
+14% +$744K
2016 Q2
6 quarters
CVS icon
22
CVS Health
CVS
$110B
$5.13M 1.87%
70,723
-11,935
-14% -$868K
2013 Q2
18 quarters
MSFT icon
23
Microsoft
MSFT
$3.8T
$4.62M 1.69%
53,959
+6,670
+14% +$547K
2013 Q2
18 quarters
XLNX
24
DELISTED
Xilinx
XLNX
$4.46M 1.63%
66,126
-2,221
-3% -$158K
2013 Q2
18 quarters
PEP icon
25
PepsiCo
PEP
$195B
$4.17M 1.52%
34,775
+665
+2% +$75.9K
2013 Q2
18 quarters

Similar funds

Brian C. Broderick's Q4 2017 Portfolio in Review

As of Q4 2017, Brian C. Broderick held 103 positions worth $274M, down 1.1% from $277M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Brian C. Broderick withdrew a net $15.6M in Q4 2017, closing 13 positions and reducing 50 holdings. Its most notable exit was Albemarle, an estimated $757K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.

Against the trend, Brian C. Broderick opened a new position in Celgene worth $884K.

  • Brian C. Broderick's largest Q4 2017 buy was Celgene: 8,470 shares worth $884K.
  • Brian C. Broderick added most to Ironwood Pharmaceuticals in Q4 2017, an estimated $5.34M increase.
  • Brian C. Broderick's biggest Q4 2017 reduction was 3M, cutting an estimated $1.88M.
  • Brian C. Broderick fully exited Albemarle in Q4 2017, selling an estimated $757K.
  • Brian C. Broderick's ten largest holdings make up 31% of its $274M portfolio in Q4 2017.
  • Brian C. Broderick opened 12 new positions and closed 13 in Q4 2017.
  • Brian C. Broderick's portfolio value fell 1.1% quarter-over-quarter to $274M.

Based on Brian C. Broderick's 13F filing for Q4 2017, filed 2 Feb 2018.